These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7603652)

  • 41. Accuracy of enteral syringes with commonly prescribed paediatric liquid medicines.
    Arenas-López S; Gurung K; Tibby SM; Calleja Hernández MÁ; Tuleu C
    Arch Dis Child; 2017 Jul; 102(7):655-659. PubMed ID: 28235838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The current evidence base for the feasibility of 48-hour continuous subcutaneous infusions (CSCIs): A systematically-structured review.
    Baker J; Dickman A; Mason S; Ellershaw J
    PLoS One; 2018; 13(3):e0194236. PubMed ID: 29538455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subcutaneous drug infusions: a review of problems and solutions.
    Mitten T
    Int J Palliat Nurs; 2001 Feb; 7(2):75-85. PubMed ID: 12271253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A miniature syringe pump for continuous administration of drugs and hormones: The Mill Hill infuser.
    Parsons JA; Rothwell D; Sharpe JE
    Lancet; 1977 Jan; 1(8002):77-8. PubMed ID: 63716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of syringe drivers: a paediatric perspective.
    McNeilly P; Price J; McCloskey S
    Int J Palliat Nurs; 2004 Aug; 10(8):399-404. PubMed ID: 15365495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two-stage model-free tests of synergy in drug combinations.
    Kelly C; Feng P; Kawashima T; Wilmes A; Miller J
    J Biopharm Stat; 2012; 22(1):54-71. PubMed ID: 22204527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Practical considerations in the administration of intravenous vasoactive drugs in the critical care setting. Part II--how safe is our practice?
    Morrice A; Jackson E; Farnell S
    Intensive Crit Care Nurs; 2004 Aug; 20(4):183-9. PubMed ID: 15288871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sorption to plastic syringes of drugs administered by syringe pump.
    Simmons A; Allwood MC
    J Clin Hosp Pharm; 1981 Mar; 6(1):71-3. PubMed ID: 7345099
    [No Abstract]   [Full Text] [Related]  

  • 49. Subcutaneous Dihydrocodeine Tartrate: Compatibility in a Syringe Pump With Other Drugs Frequently Prescribed for the Management of Symptoms Associated With Brain Tumors.
    Isherwood R; Forsyth A; Wilson A
    J Palliat Care; 2023 Jan; 38(1):5-9. PubMed ID: 34787008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability.
    Dickman A; Bickerstaff M; Jackson R; Schneider J; Mason S; Ellershaw J
    BMC Palliat Care; 2017 Mar; 16(1):22. PubMed ID: 28335763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fixed combination drug therapy.
    Shenfield GM
    Drugs; 1982 Jun; 23(6):462-80. PubMed ID: 7049658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Separation of drugs from blood contaminated syringe washings.
    Gomm PJ
    J Forensic Sci Soc; 1970 Jan; 10(1):7-12. PubMed ID: 5475995
    [No Abstract]   [Full Text] [Related]  

  • 53. Admixing drugs in a syringe.
    McConnell EA
    Nursing; 1998 May; 28(5):20. PubMed ID: 9616585
    [No Abstract]   [Full Text] [Related]  

  • 54. Protein dynamics in drug combinations: a linear superposition of individual-drug responses.
    Geva-Zatorsky N; Dekel E; Cohen AA; Danon T; Cohen L; Alon U
    Cell; 2010 Mar; 140(5):643-51. PubMed ID: 20211134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statistical analysis of drug-drug and site-site interactions with isobolograms.
    Tallarida RJ; Porreca F; Cowan A
    Life Sci; 1989; 45(11):947-61. PubMed ID: 2677570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety agency calls for old syringe drivers to be phased out, after deaths.
    Young J
    BMJ; 2011 Feb; 342():d795. PubMed ID: 21300714
    [No Abstract]   [Full Text] [Related]  

  • 57. The problem of synergism and antagonism of combined drugs.
    LOEWE S
    Arzneimittelforschung; 1953 Jun; 3(6):285-90. PubMed ID: 13081480
    [No Abstract]   [Full Text] [Related]  

  • 58. Fixed-dose combinations: a potential means to boost drug development for selected drugs.
    Oo C; Sy SKB
    Drug Discov Today; 2018 Mar; 23(3):457-459. PubMed ID: 29146518
    [No Abstract]   [Full Text] [Related]  

  • 59. The utilization of syringe drivers at a teaching hospital.
    McQuillan R; Finlay I
    Palliat Med; 1996 Jan; 10(1):52. PubMed ID: 8821189
    [No Abstract]   [Full Text] [Related]  

  • 60. Anticipatory syringe drivers: a step too far.
    Bowers B; Ryan R; Hoare S; Pollock K; Barclay S
    BMJ Support Palliat Care; 2019 Jun; 9(2):149-150. PubMed ID: 31118195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.